Stocks To Watch - True 2 Beauty Inc., (PINKSHEETS: TRTB), Connectyx Technologies Holdings Group, Inc. (PINKSHEETS: CTYX), EI Maniel International Inc (PINKSHEETS: EMLL): Sign-Up for our FREE Stock Picks TODAY!

M2 PRESSWIRE-March 18, 2011-OTC Tip Reporter: Stocks To Watch - True 2 Beauty Inc., (PINKSHEETS: TRTB), Connectyx Technologies Holdings Group, Inc. (PINKSHEETS: CTYX), EI Maniel International Inc (PINKSHEETS: EMLL): Sign-Up for our FREE Stock Picks TODAY!(C)1994-2011 M2 COMMUNICATIONS

RDATE:18032011

www.OTCtipReporter.com Stocks To Watch - True 2 Beauty Inc., (PINKSHEETS: TRTB), Connectyx Technologies Holdings Group, Inc. (PINKSHEETS: CTYX), EI Maniel International Inc (PINKSHEETS: EMLL)

Sign-Up for our FREE Stock Picks AND OUR AWARD WINNING NEWSLETTER at

www.OTCtipReporter.com

_______________________________________________________________________________

For a FREE Report Visit: www.OTCtipReporter.com

www.OTCtipReporter.com is a premier source for Top penny stocks research.

True 2 Beauty Inc. Commences Online Marketing Campaign Signs Agreement With Direct Marketing Professionals to Manage Affiliate Network Marketing

LOS ANGELES, CA -- 03/16/11 -- True 2 Beauty Inc., (PINKSHEETS: TRTB) (the "Company") (http://www.true2beautyinc.com), a leading distributor of male and female sexual potency pills and liquid products in the United States, is pleased to announce the commencement of an extensive online marketing campaign to reach millions of potential new customers. The company has signed an agreement with Direct Marketing Professionals, Inc. (DMP) to manage a comprehensive affiliate program. (http://www.dmpoffers.com)

"We are extremely excited to begin marketing our products on a revenue share basis through thousands of websites that are part of the affiliate network created by DMP. The anticipated sales should have an immediate impact on revenue and profits. Our current online business has grown organically with almost no advertising, this new affiliate program will provide exposure of our products on an enormous scale, cost effectively," states Alex Hbaiu, CEO of True 2 Beauty. "We have been working closely with DMP for the past month to launch this offer and we are very pleased with their overall professionalism in helping us create the right look and feel for our product mix."

"DMP is extremely excited to be involved in the rising success and distribution of the Libigrow family of products. We believe that our online marketing campaigns will be an additional compliment to the already existing retail distribution channel. Our experience has proven that the Internet is a very profitable media in which to market these types of products. DMP looks forward to a long-term relationship with True 2 Beauty, Inc. and launching several successful marketing campaigns," says Mike Loewenberg, President of Direct Marketing Professionals, Inc.

"Further," states Mr. Hbaiu, "This agreement is just the beginning of our planned comprehensive program to market the Libigrow brand of products to a larger audience through highly visible media platforms. We anticipate the release of our first commercial, which is in the final stages of editing, and should begin airing on television very soon."

About True 2 Beauty, Inc.

True 2 Beauty, Inc. is a leading distributor of male and female sexual potency pills and liquid products in the United States. The True 2 Beauty, Inc. line of current products includes Libigrow, Libigirl, Libiliquid Shots and the Libiliquid Relaxation Drink. More information on the Company and its line of products can be found at http://www.libigrow.com.

About Direct Marketing Professionals, Inc.

Direct Marketing Professionals Inc. is a privately held performance based marketing firm specializing in online advertising utilizing affiliate marketing to generate profitable sales for its advertisers. The corporate office is located in Apollo Beach, Florida with sales offices located in Southern California. More information is available at the following website: http://www.dmpoffers.com or by calling 1-877-819-7288.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, among others, all assumptions, expectations, predictions, intentions or beliefs about future events. You are cautioned that any such forward-looking statements are not guarantees of future performance and that a number of risks and uncertainties could cause actual results of the Company to differ materially from those anticipated, expressed or implied in the forward-looking statements. The words "believe," "expect," "anticipate," "project," "targets," "optimistic," "intend," "aim," "will" or similar expressions are intended to identify forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Risks and uncertainties that could cause actual results to differ materially from those anticipated include risks related to new and existing products, product defects and any related product recall; any projections of sales, earnings, revenue, margins or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements. The Company assumes no obligation and does not intend to update any forward-looking statements, except as required by law.

_______________________________________________________________________________

For a FREE Report Visit: www.OTCtipReporter.com

www.OTCtipReporter.com is a premier source for Top penny stocks research.

Connectyx Technologies Recent Announcement of 5,000 MedFlash Licenses Sold Just Part of Sales Traction Increasing From Recent Marketing Alliances and Trade Shows

Recent Professional Medical Conferences Resulting in Advanced Negotiations for Broad Distribution of MedFlash

STUART, FL -- 03/17/11 -- Connectyx Technologies Holdings Group, Inc. (PINKSHEETS: CTYX) ("Connectyx"), www.connectyx.com, manufacturer and distributor of the MedFlash(r), the nation's premier Personal Health and Wellness Management System (ePHM) for maintaining personal health records (PHR), announced today that the company has been experiencing significant progress in the past thirty days with market acceptance of the MedFlash, resulting in advanced negotiations with a number of professional medical organizations considering the addition of MedFlash to their list of services and offerings to their patients.

Ronn Schuman, CEO of Connectyx, said, "With our recent announcement that Selected Market Insurance Group purchasing 5,000 MedFlash licenses and forecasting a total of 50,000 licenses to be purchased over the next twelve months, it is increasingly clear that our business plan shift to targeting large organizations is working. Our presentations at recent trade shows are resulting in more qualified leads and, in many cases, requests for follow up. Based upon this success, we will be attending a number of other trade shows/ medical conferences in the next two months."

Schuman continued, "Curiously, our call center is receiving an increase in individual orders and inquiries for MedFlash which happens to offer highest gross margins for the Company."

To be added to the corporate e-mail database for corporate press releases and industry updates, investors and shareholders are requested to send an e-mail to investorrelations@connectyx.com.

MedFlash (r) Features and Benefits

The MedFlash(r) PHM Portal features a 24/7/365 call center, a USB flash drive and a smart phone application. The MedFlash(r) PHM provides additional member benefits and services including instant access to a subscriber's Emergency Medical Profile and Personal Health Record in the event of an accident or a medical emergency. First Responders such as police, emergency medical technicians (EMT's) and firefighters have access to time critical information for victims who may be comatose or unable to communicate pertinent medical history information. The MedFlash(r) PHM can be accessed on any computer, whether in an ambulance or an emergency room, securely and with complete privacy. Lifestyle and wellness features are delivered to members that have the potential to result in significant health benefits to members following the healthcare advice. With the increasing focus on cutting costs and risk mitigation by both employers and insurers, the MedFlash offers a low cost addition to the various initiatives necessary for maintaining and reducing costs of current healthcare delivery systems. For more information, see www.medflash.com.

About Connectyx

Connectyx provides unique products for the healthcare market including MedFlash(r), the electronic Personal Health Manager (ePHM). Compatible with Google Health and Microsoft's Health Vault, the MedFlash(r) ePHM is an easy-to-use Personal Health and Lifestyle Manager that is accessible using a powerful web portal suite. The MedFlash(r) ePHM portal also features a 24/7/365 call center, a USB flash drive and a smart phone application. The MedFlash(r) ePHM provides member benefits including instant access to your Emergency Medical Profile and Personal Health Record in the event of an accident or a medical emergency. Whether traveling, at work, or at home, First Responders have an invaluable advantage when they have access to this time critical information. Far more than just an emergency flash drive the MedFlash(r) PHM can be accessed on any computer, securely and with complete privacy. There are also lifestyle and wellness features that provide significant health benefits to members and risk mitigation for employers and insurers alike. Connectyx products are developed with the needs of patients, families, doctors and First Responders in mind. For more information, please visit our websites at: www.connectyx.com and www.medflash.com

Safe Harbor Act: This communication includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this communication.

_______________________________________________________________________________

For a FREE Report Visit: www.OTCtipReporter.com

www.OTCtipReporter.com is a premier source for Top penny stocks research.

El Maniel International Inc to Release Initial Results of Gold Reserves on Plot A and Plot B Situated in the Western Region of Ghana

NEW YORK, March 16, 2011 -- Further to our press release dated January 27, 2011, EI Maniel International Inc (Pink Sheets:EMLL) announced today that initial results from the geological survey of the alluvial gold mining claims known as Plot A and Plot B of 100 acres each is expected to be released by end of March 2011. "Our geologist is currently consolidating the results of Plot A and Plot B from the recent survey conducted and we believe that the initial results from the 200 acres alluvial gold mining claim situated in the region of proven gold deposits will be very significant for us to proceed with the following steps of expediting the final approvals necessary for commencement of mining operations," according to Jamie Khoo, CEO of El Maniel. "We will be working aggressively towards putting this second and larger mine into eventual commercial production gearing El Maniel towards becoming a successful emerging gold producer in Ghana, and come April 2011, El Maniel will be a revenue-generating company with multiple income stream."

The 200 acres of alluvial gold mining claim is situated in Akatreka of Wassa Amenfi West, in the Western Region of Ghana, West Africa next to Ankobra river which is well known for alluvial gold abundance. The Ankobra river is next to the north-western part of the 200 acres gold mining claim and runs all the way down next to the western portion of the gold mining claim. Plot A and Plot B is positioned in the Golden Triangle of Western Ghana where historical gold production amounts to over 168 million ounces. "We are confident that this asset will contribute significantly towards El Maniel's bottom line," stated Jamie Khoo.

El Maniel International Inc is a publicly traded company currently focused on prospecting, developing and expanding the economic potential of world class mining claims located in Ghana, West Africa and the company is committed to shareholder's value creation by ensuring constant development of current and new resources in the region. For further information and updates on El Maniel, stay tuned to www.elmaniel.com

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995: The statements contained in this release which are not historical facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward-looking statements. These risks and uncertainties include the Company's entry into new commercial businesses, the risk of obtaining financing, recruiting and retaining qualified personnel, and other risks described in the Company's Securities and Exchange Commission filings. The forward-looking statements in this press release speak only as of the date hereof, and the Company disclaims any obligation to provide updates, revisions or amendments to any forward-looking statement to reflect changes in the Company's expectations or future events.

_______________________________________________________________________________

For a FREE Report Visit: www.OTCtipReporter.com

To feature your publicly traded company in our alerts, email us at: office@OTCtipReporter.com

Let OTC Tip Reporter help advertise for your company using our effective awareness campaigns. If you're Interested in telling your story, we can help. Contact us at office@OTCtipReporter.com

About OTCtipReporter.com

www.OTCtipReporter.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies.

www.OTCtipReporter.com email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity. To subscribe to this free service, visit the OTCtipReporter Stock Report home page at http://www.OTCtipReporter.com and Sign up Free For "Daily Stock Alerts".

Join us at http://www.OTCtipReporter.com for a complimentary subscription to the most exciting online financial newsletter.

To feature your publicly traded company in our alerts, email us at: office@OTCtipReporter.com

Disclaimer: Verify all claims and do your own due diligence. OTCtipReporter.com profiles are not a solicitation or recommendation to buy, sell or hold securities. OTCtipReporter.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. OTCtipReporter.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), OTCtipReporter.com is owned and operated by OTCtipReporter.com. Neither OTCtipReporter.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this press-release, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since OTCtipReporter.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in OTCtipReporter.com statements and opinions and such statements and opinions cannot be considered independent. OTCtipReporter.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. OTCtipReporter.com services are often paid for using free-trading shares. OTCtipReporter.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

Visit us for a full Disclaimer at: http://www.otctipreporter.com/disclaimer.htm

To feature your publicly traded company in our alerts, email us at: office@OTCtipReporter.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com)).